Evidence map›Paper›PMID 31679147›Full record

ArticleAging clinical and experimental research2020

Osteosarcopenia among postmenopausal women and handgrip strength as a practical method for predicting the risk.

Buliana Hamad, Sibel Basaran, Ilke Coskun Benlidayi

Abstract read
PubMed Publisher
In one paragraph

Article in Aging clinical and experimental research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Osteosarcopenia: A Narrative Review on Clinical Studies.International journal of molecular sciences · 2022
    Review
  18. Drug discovery of sclerostin inhibitors.Acta pharmaceutica Sinica. B · 2022
    Review
  19. Sarcopenia and bone health: new acquisitions for a firm liaison.Therapeutic advances in musculoskeletal disease · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Buliana HamadDepartment of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, 01330, Adana, Turkey.
Sibel BasaranDepartment of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, 01330, Adana, Turkey. sibasaran@gmail.com.ORCID http://orcid.org/0000-0003-3228-3909
Ilke Coskun BenlidayiDepartment of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, 01330, Adana, Turkey.
Cukurova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteosarcopenia is a recently described geriatric syndrome. Studies concerning its role on physical function are relatively few.

aimTo evaluate the prevalence of osteosarcopenia and to analyze its relationship with physical function among postmenopausal women.

methodsDemographic and clinical data, fracture risk, and osteosarcopenia risk factors of 140 postmenopausal women were evaluated between April 2018 and September 2018. Body composition and bone mineral density were measured by dual-energy X-ray absorbtiometry. Handgrip strength and physical performance test results were recorded. Sarcopenia was diagnosed according to the European Working Group on Sarcopenia in Older People, whereas osteopenia/osteoporosis was diagnosed according to the World Health Organisation criteria.

resultsThe mean age of the patients was 64.1 ± 8.9 years. Among the patients, 64.3% (n = 90) were found to be osteosarcopenic. Insufficient protein and calcium intake and low physical activity level were found to be the most frequent risk factors. When further analysis was done according to the osteosarcopenia, sarcopenia-only, and osteoporosis-only groups, osteosarcopenia group revealed the lowest body mass index, skeletal mass index, handgrip strength values, and physical performance test results. The handgrip strength was found to be a determinant of osteosarcopenia and each 1-unit decrease in handgrip strength increased the risk of osteosarcopenia by 1.162 times (95% CI 1.086-1.25).

conclusionsThe prevalence of osteosarcopenia is high among postmenopausal women. It is recommended to be aware of osteosarcopenia while managing osteoporotic patients, to use handgrip strength as a simple screening method, and to consider sarcopenia treatment as an important component of osteoporosis prevention and treatment.

Indexed as

Hand StrengthOsteoporosisSarcopeniaAgedBone DensityFemaleHumansMiddle AgedPostmenopauseHandgrip strengthOsteopeniaOsteoporosisOsteosarcopeniaPostmenopausalSarcopenia

Identifiers

PMID31679147
OpenAlexW2984771192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.